NEWSWISE – Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded $2 million by the U.S. Department of Defense (DoD) to aid in the development and manufacturing of a vaccine to protect against infection by filoviruses, including the Ebola and Marburg viruses. Continue Reading